Dr. Martens plc (DOCMF)
| Market Cap | 900.11M +7.2% |
| Revenue (ttm) | 1.05B -2.6% |
| Net Income | 20.52M -48.0% |
| EPS | 0.02 -49.2% |
| Shares Out | n/a |
| PE Ratio | 43.87 |
| Forward PE | 14.56 |
| Dividend | 0.03 (3.62%) |
| Ex-Dividend Date | Aug 28, 2025 |
| Volume | 10,000 |
| Average Volume | 13,432 |
| Open | 0.9351 |
| Previous Close | n/a |
| Day's Range | 0.9351 - 0.9351 |
| 52-Week Range | 0.6180 - 1.3550 |
| Beta | 0.17 |
| RSI | 36.09 |
| Earnings Date | Jan 23, 2026 |
About Dr. Martens
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom. [Read more]
Financial Performance
In fiscal year 2025, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.
Financial numbers in GBP Financial StatementsNews
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
Dr Martens sales slip after pulling back from discounts
The firm saw shares dip in early trading as it said revenues were set to be broadly flat for the current year.
Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness
Chief Executive Ije Nwokorie said the EMEA market continued to be challenging, and that the company had taken a more disciplined promotional stance there.
UK Stock Market News: Dr Martens, Sage, Mitie
Stamping out discounting hjelps Dr Martens profits, Sage's recurring revenues tick higher, opportunities keep growing for Mitie
Dr. Martens PLC (DOCMF) Half Year 2026 Earnings Call Highlights: A Turnaround to Profit and ...
Dr. Martens PLC (DOCMF) Half Year 2026 Earnings Call Highlights: A Turnaround to Profit and Strategic Expansion
Trump tariffs force Dr Martens To hike US prices - but boot firm says it is still on track with full-year forecast
Dr Martens had previously pledged to keep prices on hold in 2025 despite high tariffs, but said it would need to make increases from the start of 2026.
Half Year 2026 Dr Martens PLC Earnings Call Transcript
Half Year 2026 Dr Martens PLC Earnings Call Transcript
Dr. Martens plc (DRMTY) Q2 2026 Earnings Call Transcript
Dr. Martens plc 2026 Q2 - Results - Earnings Call Presentation
Shabana Mahmood puts the signs up: Britain is full. No blacks, no dogs, no Irish
We had always given sanctuary to those who needed it, she said, only now we would kick them out as soon as possible Shabana Mahmood was in a determined frame of mind. It was time to get serious. No mo...
Bank of England finance chief Afua Kyei tops list of influential black Britons
Kyei leads power list showcasing black role models across business, science, technology and the arts Afua Kyei, the finance chief of the Bank of England, has been named the UK’s most influential black...
Dr Martens treads cautiously into new year with outlook intact
Dr Martens holds guidance as Americas retail stays strong, but UK lags and outlook skews second-half. The post Dr Martens treads cautiously into new year with outlook intact appeared first on Investom...
Dr. Martens: Iconic Brand At A Potential Bargain
Dr. Martens remains profitable despite recent challenges, with a strong brand moat and loyal customer base supporting its long-term investment case. Cost-cutting, improved inventory control, and a con...
Broker Tips: Dr Martens, Aberdeen, Greatland Gold
Broker tips for UK stocks that have caught our eye this week include Dr Martens, Aberdeen and Greatland Gold
New Dr Martens boss plans revival by focusing on shoes and sandals as well as boots
Ije Nwokorie (pictured), who took over this year, said the 'narrow focus on boots failed to take full advantage' of other areas of the business.
Dr. Martens plc Non-GAAP EPS of 2.40p, revenue of £787.6M
Dr. Martens plc 2025 Q4 - Results - Earnings Call Presentation
Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript
Dr Martens sees profits slide but on track for return to growth
The footwear group reported pre-tax profits of £8.8 million for the year to March 30, down from £93 million the previous year.
Dr Martens forecasts return to profit growth, shares jump
British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...
FTSE 100 Live 05 June: Dr Martens results, index flat ahead of ECB rate cut
Botched expansion puts the boot into Dr Martens
The FTSE 250 firm is predicted to report a pre-tax profit of £28 million for the year to March 31, 2025, 69 per cent down on a year ago.
Companies Reporting: Pennon, BAT, B&M, Fevertree, Dr Martens
Pennon, BAT, B&M, Fevertree, Dr Martens are amongst the FTSE 350 and other companies reporting earnings for the week of 02 June
Dr. Martens Selects Amperity to Transform Customer Data Strategy
LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...